Back to search results

Patient Navigation Program for Breast Cancer Care

This study is testing a patient navigation program to help women with a new diagnosis of breast cancer or DCIS (Ductal Carcinoma In Situ, a non-invasive form of breast cancer). This program aims to help you understand your care options, connect you with supportive services, manage any challenges you face, and improve your skills in managing cancer treatment. The study wants to see if this program can help more people enroll in and stay with their care, and understand why some people might not join. We are looking for about 126 women aged 18 or older who have breast cancer or DCIS and are facing at least one barrier to care. The study's status is currently unclear.

Study design
This is an interventional study planning to enroll 126 participants. It is testing a patient navigation program.
What's involved
You would receive patient navigation and complete questionnaires.
Compensation
Not stated in the trial record.
Follow-up
The study measures enrollment, reasons for refusal, and retention rates for up to 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06350500

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Recruiting
NAAges 18+InterventionalHealth services
Roswell Park Cancer Institute
~126 participants
Updated 2026-02-17 on ClinicalTrials.gov
What's tested:Patient NavigationQuestionnaire

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Enrollment rate
Measured over Up to 2 years
+3 more outcomes measured

Conditions

Breast Carcinoma
Breast Ductal Carcinoma in Situ

Explore related trials

Breast CarcinomaBreast Ductal Carcinoma In Situ

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Kathryn Glaser · PRINCIPAL_INVESTIGATOR · Roswell Park Comprehensive Cancer Center

Who to contact

Kathryn Glaser
[email protected]
716-845-7637
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years of age
Have a confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS)
Currently identify their gender as woman or female
Was assigned female sex at birth (AFAB)
Participant must understand the investigational nature of this study and verbally consent to participate prior to receiving any study related intervention

Exclusion

Participants who are not suspected of or diagnosed with breast cancer or Ductal Carcinoma in Situ (DCIS)
Participants who have had a previous diagnosis of any cancer
Participants who were assigned male sex or intersex at birth
Unwilling or unable to follow protocol requirements

What this trial measures

  • Enrollment rateUp to 2 years

    Enrollment rate Will be defined as the number of patients enrolled divided by the number of patients approached. The enrollment rate will be estimated with a 90% credible region obtained by Jeffrey's prior method.

  • Reasons for refusalUp to 2 years

    Reported reasons of refusal will be summarized using frequencies and relative frequencies

  • Retention RateUp to 2 years

    The number of patients that complete patient navigation divided by the number of patients enrolled

  • Reasons for discontinuationUp to 2 years

    Will be summarized using frequencies and relative frequencies